Skip to content
GLP-1 Desk
Menu

Head-to-head dispatch

HealthSource vs Roboclinic

Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.

Dispatch #31Desk pick
HealthSource

HealthSource is a telehealth weight-management platform offering compounded semaglutide and tirzepatide (injectable and oral sublingual) dispensed through a US-based FDA 503A licensed partner pharmacy.

Marked down on: No physician names or clinical leadership disclosed on public pages

vs
Dispatch #403
Roboclinic

Roboclinic is an AI-first telehealth platform, operated by BrickFi, Inc., that starts you with an AI health assistant and then routes you to a board-certified provider for GLP-1 weight-loss care.

Marked down on: Lowest rates require a 12-month plan; month-to-month runs $299/mo (semaglutide) to $399/mo (tirzepatide)

HealthSource takes this head-to-head with the higher Desk Score, 84/100 (B) against 53/100 (C) for Roboclinic. Roboclinic still holds its ground where its strengths line up with yours.

Desk Score, dimension by dimension

Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.

HealthSource

84/100

B

Overall

Roboclinic

53/100

C

Price transparency

94
20

State access

86
24

Molecule range

77
77

Onboarding speed

79
75

Support responsiveness

85
79

Licensing & trust

69
84

The spec sheet

FieldHealthSourceRoboclinic
Semaglutide$199/mo (all doses, compounded)$179/mo (12-month plan, compounded)
Tirzepatide$299/mo (all doses, compounded)$299/mo (12-month plan, compounded)
CoverageAll 50 statesCoverage not published
Brand-nameCompounded onlyCompounded only
Oral optionYesYes
Best forReaders who want compounded semaglutide or tirzepatide (injection or oral) in all 50 states from $199/mo.Readers who want aI-first GLP-1 care with all-in compounded semaglutide and tirzepatide plans.
Desk Score84/100B53/100C

The verdict

Desk pick — HealthSource

HealthSource takes this head-to-head with the higher Desk Score, 84/100 (B) against 53/100 (C) for Roboclinic. Roboclinic still holds its ground where its strengths line up with yours.

Choose HealthSource if…

Readers who want compounded semaglutide or tirzepatide (injection or oral) in all 50 states from $199/mo.

$199/mo (all doses, compounded) sema · $299/mo (all doses, compounded) tirz · All 50 states

Choose Roboclinic if…

Readers who want aI-first GLP-1 care with all-in compounded semaglutide and tirzepatide plans.

$179/mo (12-month plan, compounded) sema · $299/mo (12-month plan, compounded) tirz · Coverage not published

Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: HealthSource · Roboclinic.

Also here

CoreAge Rx tops every dispatch at 94/100

Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.

More head-to-heads

Or see the full comparison hub and the complete ranking.

Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.